Skip to main content
Best News Website or Mobile Service
WAN-IFRA Digital Media Awards Worldwide 2022
Best News Website or Mobile Service
Digital Media Awards Worldwide 2022
Hamburger Menu

Advertisement

Advertisement

World

US FDA authorises second bivalent COVID-19 booster for older adults

US FDA authorises second bivalent COVID-19 booster for older adults

A nurse administers a Moderna COVID-19 booster vaccine at an inoculation station next to Jackson State University in Jackson, Mississippi on Nov 18, 2022. (Photo: AP/Rogelio V Solis)

The US Food and Drug Administration on Tuesday (Apr 18) authorised a second dose of Omicron-targeting COVID-19 vaccines for older adults as well as those with a weak immune system.

The agency also said the updated shots from Pfizer-BioNTech and Moderna would become the new primary COVID-19 vaccine, and withdrew its emergency-use authorisation for the older messenger RNA vaccines that target only the original version of coronavirus.

People aged 65 years and older can now receive a second dose of updated booster four months after the first, while immunocompromised people can get an additional shot of the updated vaccine after two months, the agency said.

FDA's decision comes a day before the Centers for Disease Control and Prevention's (CDC) panel of expert advisers' meeting on updating COVID-19 vaccination guidelines.

The CDC would have to recommend the second Omicron-tailored shots from Pfizer-BioNTech and Moderna for them to become widely available.

The FDA authorised the bivalent COVID-19 boosters in August that target the BA.4 and BA.5 Omicron subvariants, along with the original strain of the coronavirus.

Only around 17 per cent of the US population has received the bivalent boosters, but among people aged 65 years and older, the uptake is higher, about 42.6 per cent of them have received their first shot of the updated vaccines.

The authorisation withdrawal for Moderna and Pfizer-BioNTech's older vaccines, comes at a time when the FDA plans to shift to an annual COVID-19 booster campaign with an updated strain, similar to the way Americans get their flu shots.

The FDA also said it will hold another meeting of its advisers in June to discuss the strain composition of the COVID-19 vaccines for the fall season, with mRNA vaccine manufacturers expected to update their shots once the specific strains are selected.

Source: Reuters/ec

Advertisement

Also worth reading

Advertisement